It was also found that hOCT2 mRNA is expressed in ovarian cancer cell lines; however, its expression in clinical ovarian cancer specimens was low and did not correlate with the treatment outcome of platinum-based regimens [136]. This evidence concerns the gene SLC22A2 and ovarian cancer.